Division of Norgine BV
Latest From Norgine Pharma
UK Innovation, EU Regulation And Digital Transformation Are Top Themes For Medtechs At NHS Expo 2018
NHS England chief Simon Stevens has a habit of stealing headlines in UK health-care circles, and his CAR-T cell therapy approval announcement did the trick at the NHS 2018 Innovation Expo. But medtech innovation schemes and furthering the UK digital agenda emerged as main talking points at the meeting.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
When Olympus Corp. re-entered the M&A arena after five years of "back to the basics," it was via the purchase of a company that meets every parameter of its requirements. Nacho Abia says that OR integrator Image Stream Medical should also help the Japanese multinational stay on course to meet value-based – and ambitious mid-term sales – targets.
Recent product approvals in the U.S have included major milestones for two Japanese companies and their U.S. alliance partners. But commercial prospects for the two very different drugs are seen varying widely.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.